Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy

INTRODUCTION: B-cell depletion has been shown to be an effective strategy for the majority of patients with membranous nephropathy (MN), and in PLA2R-positive MN, immunologic remission (improvement or elimination of measurable serum anti-PLA2R antibodies) precedes renal remission. Yet, cases exist o...

Descripción completa

Detalles Bibliográficos
Autores principales: Geara, Abdallah S., Bhoj, Vijay, Hogan, Jonathan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677711/
https://www.ncbi.nlm.nih.gov/pubmed/36751489
http://dx.doi.org/10.1159/000515087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677711/
https://www.ncbi.nlm.nih.gov/pubmed/36751489
http://dx.doi.org/10.1159/000515087

Ejemplares similares